On National Stock Exchange (NSE), the Bank of Maharashtra is quoting Rs 31.75, up 1.44%. The bank’s stock rose 51.91% in 2022, compared with the Nifty’s gain of 1.86% and the Nifty Pharma index’s gain of 52.81%.

• NTPC and ONGC Joint Venture Arms Declared Highest for Ayana Renewable 
• US Markets Slips as Investors Book Profit 
• Boat Gears Up for $300-500 Million IPO
• Stocks Under F&O Ban: Gujarat Narmada Valley, Hindustan Copper, and Others
• Pacific Atolls Face $10 Billion Challenge from Rising Seas: World Bank

On January 13, the bank gained for a third straight session. The stock is quoting at Rs 31.75, up 1.44%. The benchmark Nifty is up around 0.33% daily, with 17,916.25. The Sensex is at 60,168.85, up 0.35%. Bank of Maharashtra has dropped around 6.89% in the previous month.

Meanwhile, the Nifty Pharma index of which Bank of Maharashtra dropped around 6.53% on December 2022 and recently traded the stock at 4,223.1, up 0.71% on the day. As of January 13, 2022, 250.78 lakh shares had traded in the stock, compared with the 732.4 lakh daily average for the previous month.

Based on TTM earnings, the PE of the stock is 12.6 as of September 2022 end.